NASDAQ
Oramed Pharmaceuticals Inc. (ORMP) has a revenue compound annual growth rate of -5.90% over 5 years and 26.93% over 10 years. Revenue CAGR shows the compound annual growth rate of a company's total sales, indicating the pace of top-line expansion.
No price data available for this timeframe.